Results 151 to 160 of about 23,498 (195)

Natalizumab-Associated Progressive Multifocal Leukoencephalopathy After Natalizumab Extended Interval Dosing Therapy in Japan. [PDF]

Neurol Neuroimmunol Neuroinflamm
Takahashi K, Nakahara J, Miura Y, Ae R, Nakamichi K, Harada M, Mori K, Sanjo N, Yukitake M, Yokote H, Hamaguchi T, Yamada M, Takao M.   +12 more
europepmc   +1 more source

Inflammatory bowel disease therapies and demyelinating diseases: a practical guide to therapeutic benefit and risk. [PDF]

J Crohns Colitis
Honap S, Debouverie M, Filippi M, Selchen D, Jairath V, Danese S, Peyrin-Biroulet L.   +6 more
europepmc   +1 more source

Prediction and Characterization of Glycated Peptides and Proteins using Hydrophilic Interaction Liquid Chromatography coupled with Mass Spectrometry (HILIC-MS). [PDF]

J Biomol Tech
Priya S, Kowalski EL, Popov M, Orlando R.   +3 more
europepmc   +1 more source

The Immunosuppression Paradox in Multiple Sclerosis: Are We Fueling the Fire by Suppressing Immunity in an Epstein-Barr Virus-Linked Disease? [PDF]

Open Forum Infect Dis
Onisiforou A.
europepmc   +1 more source

Clinical Experience With Biologic Disease-Modifying Therapy in Relapsing-Remitting Multiple Sclerosis: A Case Report and Review of Literature. [PDF]

Clin Case Rep
Nazneen PS, Dorji T, Yangzom S, Natarajan RV.   +3 more
europepmc   +1 more source

Comprehensive Study of Drug-Associated Severe Allergic Reactions: An Analysis of High-Risk Medications and Epidemiological Trends Based on the FAERS Database. [PDF]

Allergy Asthma Immunol Res
Mo W, Ouyang M, Yang H, Kong W.
europepmc   +1 more source